Parexel's Ethnobridging Expert Discusses Its Importance as a Development Strategy
CER and Personalized Medicine: Insights from the Experts
eClinical Software Trends, Part 2
eClinical Software Trends, Part 1
INC's CEO Discusses the Current CRO Climate
Jim Ogle, CEO of INC Research, offers his take on industry consolidation, what it means for the future, and INC's own role and strategy in its recent acquisitions.
Shire's Move from R&D to Search and Development: An IT Perspective, Part 2
Shire's Move from R&D to Search and Development: An IT Perspective, Part I
The Business Behind Clinical Trials
Web Solutions Can Improve Document Exchange
Comparator Drug Sourcing - The Benefits of Taking a Strategic Approach
Getting Data with Benefits
UBC's Adam Butler Discusses Its New eClinical Company
Constructing Price Indexes for Clinical Trials
Comprehend Systems' Discusses New Analytics Offering
Global Regulatory Capacity
Web Portals, Dashboards and Technology Trends from Health Decisions CEO
Preparing for Future Trends in Risk Management
Merck's Biosimilars Business, from Parexel's Perspective
Trial Budget Clarity
Get Meaning From Your Data
Build A Drug's Value in Early
INC Research Discusses How CROs Can Help Oncology Trials
Biosimilars in the US
Diabetes and Obesity Series
Diabetes & Obesity Podcasts: Pediatric Clinical Trials
Diabetes & Obesity Podcasts: Finding the Patients
Regulatory and Safety: Obesity Drugs
Diabetes & Obesity Podcasts: Role of Biomarkers
Diabetes & Obesity Podcasts: Challenges to the Site
Diabetes & Obesity Podcast: Challenges Sponsors Face in Diabetes Trials
